Replimune takes third swing at cancer drug approval following ‘productive’ FDA talks - BioPharma Dive
BioPharma Dive · 2026-05-29
TOPIC
Biotech & FDA News
FDA drug approvals, clinical trial results, and biotech stock-moving news.
Related Tickers
$LLY · Eli Lilly$NVO · Novo Nordisk$JNJ · Johnson & Johnson$PFE · Pfizer$MRK · Merck$ABBV · AbbVie$UNH · UnitedHealthLatest Coverage
Royalty Pharma stock hits 52-week high at 54.82 USD
Investing.com · 2026-05-29
Vertex Pharmaceuticals Incorporated (VRTX) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
Seeking Alpha · 2026-05-29
Replimune to resubmit twice-rejected drug for approval after FDA shakeup
CNBC Top · 2026-05-29
Tempus stock rises after FDA approval for tumor-only test
Investing.com · 2026-05-29
Tempus AI receives FDA approval for tumor-only genomic test
Investing.com · 2026-05-29
Sunshine Biopharma receives patent for coronavirus treatment compounds
Investing.com · 2026-05-29
Replimune reaches agreement with FDA on melanoma drug resubmission
Investing.com · 2026-05-29
12M Americans have BPH; one biotech is testing a plant-based option - Stock Titan
Stock Titan · 2026-05-29
Cantor Fitzgerald raises ARS Pharmaceuticals stock price target on CSU program potential
Investing.com · 2026-05-29
Form 6K Collplant Biotechnologies Ltd For: 29 May
Investing.com · 2026-05-29
Atea Pharmaceuticals: I'm Optimistic Ahead Of Critical HPV Catalyst
Seeking Alpha · 2026-05-29
Aspen Pharmacare Holdings Limited (APNHY) Shareholder/Analyst Call Prepared Remarks Transcript
Seeking Alpha · 2026-05-29
Abbott (ABT) Wins FDA and EU Approval for an AI-Powered Tool That Guides Artery Stent Placement
Insider Monkey · 2026-05-29
Hemogenyx Pharmaceuticals grants options, extends warrants
Investing.com · 2026-05-29
Why Collegium Pharmaceutical Inc. (COLL) Stock Is Gaining Attention for Its ADHD Portfolio
Insider Monkey · 2026-05-29
Malaysia’s Largest Pharma Chain Big Caring Is Said to Seek $750 Million in IPO
Bloomberg Markets · 2026-05-29
Sanofi is building its own AI ecosystem to give the French pharma giant an edge
Fortune · 2026-05-29
FDA approves expanded Tremfya label for joint damage inhibition
Investing.com · 2026-05-28
Innovent Biologics, Pfizer strike $10.5 bln cancer drug deal amid China biotech boom - Reuters
Reuters · 2026-05-28
This Biotech Stock Is Stuck in the Red. Its Cancer Portfolio Is About to Change the Narrative.
Barrons.com · 2026-05-28
aTYR Pharma director Paul Schimmel buys $49,630 in common stock
Investing.com · 2026-05-28
Form 144 JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY For: 28 May
Investing.com · 2026-05-28
FDA advisers recommend COVID vaccines be updated to target current dominant variant
Investing.com · 2026-05-28
Form 144 Eton Pharmaceuticals For: 28 May
Investing.com · 2026-05-28
Inside the hiring process for biotech CEOs
Pharma Voice · 2026-05-28
Lilly to present phase 3 data on Foundayo, retatrutide at ADA
Investing.com · 2026-05-28
VERAXA Biotech Secures $27.5M Financing, to Go Public Via SPAC
Exec Edge · 2026-05-28
Personalis: Initiating Coverage Of Cancer Testing Biotech With A Buy Rating
Seeking Alpha · 2026-05-28
Ionis Pharmaceuticals: Bull Run Can Continue As Major Catalysts Approach
Seeking Alpha · 2026-05-28
If Decades of History Tell Us Anything, This Biotech Near $50 Is Primed to Skyrocket
24/7 Wall St. · 2026-05-28
This biotech is leading what could be a 'GLP-1 moment for hair loss,' says BTIG
CNBC Top · 2026-05-28
Medicus Pharma secures up to $22M in non-dilutive financing facility
Proactive · 2026-05-28
From biotech to orbit: Rocket One’s AI and space re-brand sends shares flying
Investing.com · 2026-05-28
Aspire Biopharma announces $5m share buyback, DCS acquisition
Investing.com · 2026-05-28
From biotech to orbit: Rocket One's AI and space re-brand sends shares flying - Reuters
Reuters · 2026-05-28
Small biotech firms quicker to 'latch onto' AI than big ones, says Tencent Healthcare President
Reuters · 2026-05-28
Small biotech firms quicker to ’latch onto’ AI than big ones, says Tencent Healthcare President
Investing.com · 2026-05-28
Recce Pharmaceuticals targets Middle East expansion with 10-year R327G licensing deal
Proactive · 2026-05-28
Eli Lilly Expands Into Infectious Diseases, Retatrutide Adds Another Phase 3 Win
Seeking Alpha · 2026-05-28
Frequently Asked Questions
What is Biotech & FDA?
FDA drug approvals, clinical trial results, and biotech stock-moving news.
Which stocks are in the Biotech & FDA space?
Commonly tracked tickers include LLY, NVO, JNJ, PFE, MRK. Catalayer maintains curated ticker pages with live news at /stocks/ for each.
Why does Biotech & FDA matter for investors?
Biotech & FDA influences market sentiment, sector rotation, and individual stock valuations. Catalayer’s Market Intelligence tier adds AI-powered event classification so you can see which stories are likely to move prices.
How can I monitor Biotech & FDA in real time?
Create a custom keyword monitor on Catalayer with any of these terms: fda, biotech, clinical trial, drug approval, pharma, gene therapy. Free accounts get 1 monitor; Plus ($29/mo) unlocks 5 simultaneous monitors with boolean rules.
Monitor Biotech & FDA News live
Get alerted whenever news matches this topic.